Naproxen and Optivar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naproxen (naproxen) and Optivar (azelastine hydrochloride). Common drug interactions include haematochezia among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Naproxen and Optivar. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,034 Naproxen users. Check the latest studies of Naproxen.

What is Optivar?

Optivar has active ingredients of azelastine hydrochloride. eHealthMe is studying from 367 Optivar users. Check the latest studies of Optivar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

12 people who take Naproxen and Optivar together, and have interactions are studied.

Naproxen and Optivar drug interactions.

What are the common drug interactions of Naproxen and Optivar, by gender? *:

female:

  1. Haematochezia (passage of stools containing blood)
  2. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  3. Injection site pain
  4. Leukopenia (less number of white blood cells in blood)
  5. Aortic arteriosclerosis (hardening of the aortic arteries)
  6. Aortic calcification (aortic calcification sign of heart valve disease)
  7. Aphasia (damage to the parts of the brain that control language)
  8. Blood pressure increased
  9. Blood prolactin increased
  10. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)

male:

  1. Asthma
  2. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  3. Headache (pain in head)
  4. Hypersensitivity
  5. Hypertension (high blood pressure)
  6. Nausea (feeling of having an urge to vomit)
  7. Polyp
  8. Rash
  9. Type 2 diabetes mellitus

What are the common drug interactions of Naproxen and Optivar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Complex partial seizures (epileptic seizure)
  3. Confusional state
  4. Deja vu (the experience of thinking that a new situation had occurred before)
  5. Depression
  6. Dissociation
  7. Dysphonia (speech disorder attributable to a disorder of phonation)
  8. Fatigue (feeling of tiredness)
  9. Feeling hot
  10. Flushing (the warm, red condition of human skin)

30-39:

n/a

40-49:

  1. Blood pressure increased
  2. Heart rate increased
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

  1. Asthma
  2. Deafness
  3. Haematochezia (passage of stools containing blood)
  4. Headache (pain in head)
  5. Hypertension (high blood pressure)
  6. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  7. Leukopenia (less number of white blood cells in blood)
  8. Nausea (feeling of having an urge to vomit)

60+:

  1. Aortic arteriosclerosis (hardening of the aortic arteries)
  2. Aortic calcification (aortic calcification sign of heart valve disease)
  3. Small cell lung cancer (small cell cancer tumour of lung)
  4. Type 2 diabetes mellitus
  5. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  6. Cerebral atrophy (decrement in size of brain)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Pericardial effusion (fluid around the heart)
  10. Pneumonia

What are the existing conditions these people have? *

  1. Asthma: 5 people, 41.67%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 16.67%
  3. Type 2 Diabetes: 1 person, 8.33%
  4. High Blood Cholesterol: 1 person, 8.33%
  5. Birth Control: 1 person, 8.33%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 8.33%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%
  8. Depression: 1 person, 8.33%
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 8.33%
  10. Infection: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Naproxen and Optivar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naproxen and Optivar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Optivar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Optivar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naproxen and azelastine hydrochloride (the active ingredients of Naproxen and Optivar, respectively), and Naproxen and Optivar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: